Drug Search Results

Threonine

Alternative Names: threonine, clinimix, plenamine, clinimix e, travasol, premasol - sulfite-free (amino acid), freamine iii, trophamine, aminosyn ii, hepatamine, aminosyn-pf, procalamine, prosol, clinisol, kabiven, perikabiven
Latest Update: 2024-12-13
Latest Update Note: News Article

Product Description

Mechanisms of Action: Protein Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Threonine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success

Recent News Events

Date	Type	Title
12/19/2024	News Article	Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy
12/13/2024	News Article	Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101
11/19/2024	News Article	RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development
10/08/2024	News Article	Amino Acids Market Size to Worth Around USD 69.11 Billion by 2034

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions